Clinical Study

Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer

Figure 1

Cumulative incidence of biochemical recurrence (BCR) of prostate cancer after salvage radiation therapy (SRT) for patients with low (≤9.0 mg/dL), moderate (>9.0 and ≤9.35 mg/dL), and high (>9.35 mg/dL) pre-SRT serum calcium levels.
239241.fig.001